Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

NCT00559689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2009-03-16

No results posted yet for this study

Summary

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Conditions

Interventions

DRUG

Budesonide,hydrofluoroalkane-beclomethasone dipropionate

receive twice-daily administration

DRUG

Budesonide,hydrofluoroalkane-beclomethasone

once-daily administration at bedtime

Sponsors & Collaborators

  • Hamamatsu University

    lead OTHER

Principal Investigators

  • Kingo Chida, MD,PhD

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00559689 on ClinicalTrials.gov